Does RISANKIZUMAB-RZAA Cause Dysgeusia? 34 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Dysgeusia have been filed in association with RISANKIZUMAB-RZAA. This represents 0.1% of all adverse event reports for RISANKIZUMAB-RZAA.
34
Reports of Dysgeusia with RISANKIZUMAB-RZAA
0.1%
of all RISANKIZUMAB-RZAA reports
0
Deaths
4
Hospitalizations
How Dangerous Is Dysgeusia From RISANKIZUMAB-RZAA?
Of the 34 reports, 4 (11.8%) required hospitalization.
Is Dysgeusia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Dysgeusia?
NIRMATRELVIR\RITONAVIR (7,381)
SUNITINIB MALATE (1,226)
SODIUM (1,216)
LENALIDOMIDE (1,180)
LIFITEGRAST (1,067)
CABOZANTINIB S-MALATE (777)
CLARITHROMYCIN (717)
VISMODEGIB (706)
ADALIMUMAB (674)
PALBOCICLIB (620)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Dysgeusia Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA